Riskpilot← Back to search

Sign in Get full access

OruPharma i Örebro AB

ABActive

Org 5569293821Drevevägen 18 CResearch and experimental development on natural sciences and engineering · NACE 7210Est. 20130 employees

Revenue 2025

SEK 210K

+385% vs 2024

EBITDA margin

73.3%

+480% vs 2024

Equity ratio

90.4%

Financial strength

Net profit 2025

SEK 129K

+422% vs 2024

EBITDA — year on yearSEK millions

Key figuresAnnual report 2025

Revenue	SEK 210K	+385%
EBITDA	SEK 154K	+480%
Net profit	SEK 129K	+422%
Total assets	SEK 610K	+40%
Equity	SEK 551K	+31%
Employees	0	—

Company information

Legal name

OruPharma i Örebro AB

Org number

5569293821

Legal form

Aktiebolag

NACE code

7210 · Research and experimental development on natural sciences and engineering

Founded

19 april 2013

Share capital

SEK 50 000

Employees

0

VAT registered

Yes

Audit selected

No

Last report

2025-12-31

Financial year

January – December

Signatory rights

Firman tecknas av styrelsen Firman tecknas var för sig av ledamöterna

Company purpose

Bolaget skall bedriva utveckling av nya användningsområden för befintliga läkemedel, identifiering av nya läkemedelskandidater samt annan därmed förenlig verksamhet.

Contact

Address

Drevevägen 18 C

Email

per-erik.olsson@oru.se

Risika for professionals

Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.

Visit risika.com